Skip to search formSkip to main contentSkip to account menu

Pyrimethamine / Sulfadoxine

Known as: PYRIMETHAMINE/SULFADOXINE, sulphadoxine-pyrimethamine, fanasil, pyrimethamine drug combination 
A combination product containing pyrimethamine and sulfadoxine. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
BackgroundChange of Kenyan treatment policy for uncomplicated malaria from sulphadoxine-pyrimethamine to artemether-lumefantrine… 
Highly Cited
2007
Highly Cited
2007
BACKGROUND Combination antimalarial therapy is advocated to improve treatment efficacy and limit selection of drug-resistant… 
Review
2006
Review
2006
BACKGROUND Malaria contributes to maternal illness and anaemia in pregnancy, especially in first-time mothers, and can harm the… 
Review
2002
Review
2002
This paper seeks to define and quantify the influence of drug elimination half-life on the evolution of antimalarial drug… 
Highly Cited
2000
Highly Cited
2000
Pyrimethamine (PM) plus sulfadoxine (SD) is the last remaining affordable drug for treating uncomplicated malaria in Africa. The… 
Highly Cited
1999
Highly Cited
1999
Summary objectives  To examine in pregnant women the relationship between HIV infection and malaria prevalence and to determine… 
Highly Cited
1998
Highly Cited
1998
The lack of suitable antimalarial agents to replace chloroquine and pyrimethamine/sulfadoxine threatens efforts to control the…